★★★★★ 5
Very soft
Color: White, Size: King
Decent sheetSet for the Price
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 24, 2026
dr. reddy's labs glp-1 receptor agonist Dr. Reddy's has just launched Obeda, India's first DCGI-approved generic semaglutide injection for Type 2 diabetes, at just ₹4,200/month
Marsoni
M251S
Get it in 3 business days with 1 day shipping.
Friday, May 29
Real Talk: 12% of Americans report using GLP 1 medications Cardiovascular and mortality outcomes with GLP 1 receptor agonists vs other glucose lowering drugs in individuals with NAFLD and type 2 diabetes: a large population based matched cohort study Diabetologia Springer Nature Link GLP 1 Drugs and Weight Loss: Benefits, Side Effects, and New Research GLP 1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors JACC: Heart Failure An analysis on the role of glucagon like peptide 1 receptor agonists in cognitive and mental health disorders Nature Mental Health Researchers move closer to matching patients with GLP 1 drug that works best for them Reuters
Quick Dispatch:
Your dr. reddy's labs glp-1 receptor agonist Dr. Reddy's has just launched Obeda, India's first DCGI-approved generic semaglutide injection for Type 2 diabetes, at just ₹4,200/month orders ship within 1-2 business days.
Delivery Options:
- Standard: 3-7 business days
- Fast: 2-3 business days
- Express: 1-2 business days
Order Tracking:
You'll receive a tracking link by email once your dr. reddy's labs glp-1 receptor agonist Dr. Reddy's has just launched Obeda, India's first DCGI-approved generic semaglutide injection for Type 2 diabetes, at just ₹4,200/month ships.
Need Help?
Questions about dr. reddy's labs glp-1 receptor agonist Dr. Reddy's has just launched Obeda, India's first DCGI-approved generic semaglutide injection for Type 2 diabetes, at just ₹4,200/month, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for dr. reddy's labs glp-1 receptor agonist Dr. Reddy's has just launched Obeda, India's first DCGI-approved generic semaglutide injection for Type 2 diabetes, at just ₹4,200/month in your area.
Get Shipping Estimates
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
Dr Reddy's Enters the GLP-1 Race with Obeda: India's First Generic Semaglutide Launch
21.72
GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes
29.75
India's Semaglutide Revolution: Big Pharma Race with Dr. Reddy's, Glenmark, and Zydus, ETPharma
25.99
“Weighing In” on GLP-1 Receptor Agonists for People With HIV
26.77
With the launch of Obeda®, India's first DCGI-approved semaglutide injection for Type 2 Diabetes, we are excited to support diabetes care in India with high-quality, accessible and affordable treatment. In a head-to-head
23.01
GLP-1 Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways
24.10
Dr. Reddy's Laboratories Announces Health Canada Approval for Generic Semaglutide Injection in Canada
20.37
4.6 ★★★★★
Based on 209 reviews
Sort
Product Reviews
★★★★★ 5
I like the color and was ship
Color: White, Size: Queen
Soft material. Good quality
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 25, 2026
★★★★★ 3
They are soft and very nice looking the price is okay
It doesn't fit as well as it should on the corners other than that they're okay I they seem to wash up really well they don't wrinkle real bad either thank you
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 4, 2026
★★★★★ 5
Satisfied
Color: Pink, Size: King
Pretty pink makes me feel so girly girly. Meets my requirements soft and comfortable.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 19, 2026
★★★★★ 5
Softness and a good price
Color: White, Size: Queen
I liked the quality of the fabric—it's very soft.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 29, 2026
recommand products
Tirzepatide trial shows additional 21.1% weight loss following intensive lifestyle intervention
22.37
Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial
29.85
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
23.64
For the first time, tirzepatide and semaglutide were put in the same trial. SURMOUNT-5. Phase 3b RCT. 751 adults with obesity, no diabetes. 72 weeks. Both drugs at maximum tolerated dose. The
29.88
CTN-0152: Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder: A Pragmatic, Multi-Site, Double-Blind, Randomized, Placebo-Controlled Trial (TAB) – CTN Dissemination Library
20.69